<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1214" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1214/" /><meta name="ncbi_pagename" content="Mucolipidosis IV - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Mucolipidosis IV - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Mucolipidosis IV" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2015/07/30" /><meta name="citation_author" content="Raphael Schiffmann" /><meta name="citation_author" content="Yulia Grishchuk" /><meta name="citation_author" content="Ehud Goldin" /><meta name="citation_pmid" content="20301393" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1214/" /><meta name="citation_keywords" content="Mucolipin-1" /><meta name="citation_keywords" content="MCOLN1" /><meta name="citation_keywords" content="Mucolipidosis IV" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Mucolipidosis IV" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Raphael Schiffmann" /><meta name="DC.Contributor" content="Yulia Grishchuk" /><meta name="DC.Contributor" content="Ehud Goldin" /><meta name="DC.Date" content="2015/07/30" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1214/" /><meta name="description" content="Mucolipidosis IV is characterized by severe psychomotor delay evident by the end of the first year of life and slowly progressive visual impairment during the first decade as a result of a combination of corneal clouding and retinal degeneration. By the end of the first decade of life and certainly by their early teens, all individuals with typical mucolipidosis IV have severe visual impairment as a result of retinal degeneration. Neurodegeneration is thought to occur in no more than 15% of individuals. About 5% of individuals have atypical mucolipidosis IV, often manifest as less severe psychomotor retardation and/or eye findings. Although in the past, mucolipidosis IV was considered an Ashkenazi Jewish disease, currently most affected individuals are non-Ashkenazi Jewish." /><meta name="og:title" content="Mucolipidosis IV" /><meta name="og:type" content="book" /><meta name="og:description" content="Mucolipidosis IV is characterized by severe psychomotor delay evident by the end of the first year of life and slowly progressive visual impairment during the first decade as a result of a combination of corneal clouding and retinal degeneration. By the end of the first decade of life and certainly by their early teens, all individuals with typical mucolipidosis IV have severe visual impairment as a result of retinal degeneration. Neurodegeneration is thought to occur in no more than 15% of individuals. About 5% of individuals have atypical mucolipidosis IV, often manifest as less severe psychomotor retardation and/or eye findings. Although in the past, mucolipidosis IV was considered an Ashkenazi Jewish disease, currently most affected individuals are non-Ashkenazi Jewish." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1214/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/ml4/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1214/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE893BB9DFC8AE110000000004B00232.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1214_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1214_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ml3c/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/mps1/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1214_"><span class="title" itemprop="name">Mucolipidosis IV</span></h1><p class="contrib-group"><span itemprop="author">Raphael Schiffmann</span>, MD, MHSc, <span itemprop="author">Yulia Grishchuk</span>, PhD, and <span itemprop="author">Ehud Goldin</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1214_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1214_ai__"><div class="contrib half_rhythm"><span itemprop="author">Raphael Schiffmann</span>, MD, MHSc<div class="affiliation small">Director, Institute of Metabolic Disease<br />Baylor Research Institute<br />Dallas, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.htlaehrolyab@nnamffihcs.leahpar" class="oemail">ude.htlaehrolyab@nnamffihcs.leahpar</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Yulia Grishchuk</span>, PhD<div class="affiliation small">MGH Center for Human Genetic Research / Harvard Medical School<br />Boston, Massachusetts<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.dravrah.hgm@kuhchsirgy" class="oemail">ude.dravrah.hgm@kuhchsirgy</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Ehud Goldin</span>, PhD<div class="affiliation small">Section on Molecular Neurogenetics<br />Medical Genetics Branch<br />National Human Genome Research Institute<br />National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.liam@enidlog" class="oemail">vog.hin.liam@enidlog</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">January 28, 2005</span>; Last Update: <span itemprop="dateModified">July 30, 2015</span>.</p><p><em>Estimated reading time: 17 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="ml4.Summary" itemprop="description"><h2 id="_ml4_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Mucolipidosis IV is characterized by severe psychomotor delay evident by the end of the first year of life and slowly progressive visual impairment during the first decade as a result of a combination of corneal clouding and retinal degeneration. By the end of the first decade of life and certainly by their early teens, all individuals with typical mucolipidosis IV have severe visual impairment as a result of retinal degeneration. Neurodegeneration is thought to occur in no more than 15% of individuals. About 5% of individuals have atypical mucolipidosis IV, often manifest as less severe psychomotor retardation and/or eye findings. Although in the past, mucolipidosis IV was considered an <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> disease, currently most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are non-Ashkenazi Jewish.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Mucolipidosis IV is suspected in individuals with typical clinical findings and elevated plasma gastrin concentration or polymorphic lysosomal inclusions in skin or conjunctival biopsy. Identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>MCOLN1</i> confirms the diagnosis. The two variants, c.406-2A&#x0003e;G and 6.4 kb del (also known as g.511_6943del), account for 95% of pathogenic variants in individuals of <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> heritage.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Speech therapy; physical therapy for spasticity and ataxia; ankle-foot orthotics (AFOs) as needed; antiepileptic drugs as needed; topical lubricating eye drops, artificial tears, gels, or ointments for ocular irritation; surgical correction of strabismus; high-contrast black and white materials for those with visual impairment.</p><p><i>Prevention of secondary complications:</i> Physical therapy to prevent permanent joint contractures; oral iron to prevent iron deficiency anemia from poor absorption of dietary iron.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Mucolipidosis IV is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible for families in which both <i>MCOLN1</i> pathogenic variants have been identified.</p></div></div><div id="ml4.Diagnosis"><h2 id="_ml4_Diagnosis_">Diagnosis</h2><div id="ml4.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Mucolipidosis IV <b>should be suspected</b> in any individual with the following clinical and laboratory findings.</p><p><b>Clinical findings</b></p><ul><li class="half_rhythm"><div>Early onset of developmental delay whether static, as in cerebral palsy, or progressively declining with loss of previously acquired cognitive and motor abilities [<a class="bk_pop" href="#ml4.REF.altarescu.2002.306">Altarescu et al 2002</a>]</div></li><li class="half_rhythm"><div>Dystrophic retinopathy with or without corneal clouding [<a class="bk_pop" href="#ml4.REF.smith.2002.588">Smith et al 2002</a>]</div></li></ul><p><b>Laboratory findings.</b> Plasma gastrin concentration is elevated in virtually all individuals with mucolipidosis IV (mean 1507 pg/mL; range 400-4100 pg/mL) (normal 0-200 pg/mL) [<a class="bk_pop" href="#ml4.REF.schiffmann.1998.1207">Schiffmann et al 1998</a>, <a class="bk_pop" href="#ml4.REF.altarescu.2002.306">Altarescu et al 2002</a>].</p></div><div id="ml4.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of mucolipidosis IV <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>MCOLN1</i> (see <a class="figpopup" href="/books/NBK1214/table/ml4.T.summary_of_molecular_genetic_testi/?report=objectonly" target="object" rid-figpopup="figml4Tsummaryofmoleculargenetictesti" rid-ob="figobml4Tsummaryofmoleculargenetictesti">Table 1</a>) or (if <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> is unavailable and/or uninformative) identification of characteristic inclusions on <a href="#ml4.Biopsy">skin biopsy or conjunctival swab</a>.</p><div id="ml4.Molecular_Genetic_Testing"><h4>Molecular Genetic Testing</h4><p>Approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>.</p><p><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>MCOLN1</i> is performed first, followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</p><p>In individuals of <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> ancestry targeted analysis for the two common pathogenic variants &#x02013; <a class="figpopup" href="/books/NBK1214/table/ml4.T.selected_mcoln1_pathogenic_variant/?report=objectonly" target="object" rid-figpopup="figml4Tselectedmcoln1pathogenicvariant" rid-ob="figobml4Tselectedmcoln1pathogenicvariant">c.406-2A&#x0003e;G</a> and a 6.4-kb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> beginning in the 5&#x02019;UTR and extending into <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 6 &#x02013; can be performed first, as they account for 95% of pathogenic variants in this population. An estimated 70% of individuals with mucolipidosis IV are of Ashkenazi Jewish heritage [<a class="bk_pop" href="#ml4.REF.altarescu.2002.306">Altarescu et al 2002</a>].</p><ul><li class="half_rhythm"><div>Approximately 60% of individuals with mucolipidosis IV of <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> heritage in the US are homozygotes for the c.406-2A&#x0003e;G <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> acceptor <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>An estimated 33% are compound heterozygotes for the two common pathogenic variants [<a class="bk_pop" href="#ml4.REF.wang.2001.87">Wang et al 2001</a>, <a class="bk_pop" href="#ml4.REF.goldin.2004a.460">Goldin et al 2004a</a>].</div></li><li class="half_rhythm"><div>Only one individual <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the 6.4-kb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> has been identified [<a class="bk_pop" href="#ml4.REF.bargal.2000.118">Bargal et al 2000</a>, <a class="bk_pop" href="#ml4.REF.bassi.2000.1110">Bassi et al 2000</a>, <a class="bk_pop" href="#ml4.REF.sun.2000.2471">Sun et al 2000</a>].</div></li></ul><p>Note: The common 6.4-kb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> cannot be detected by routine sequencing. Other methods such as <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> or a <a class="def" href="/books/n/gene/glossary/def-item/genotyping/">genotyping</a> assay specifically designed to detect this deletion (e.g., breakpoint <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> or <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>-specific primer extension) must be employed.</p><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>MCOLN1</i> and other genes of interest (see <a href="#ml4.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>, and mitochondrial sequencing may be considered if serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) fails to confirm a diagnosis in an individual with features of mucolipidosis IV.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="ml4.T.summary_of_molecular_genetic_testi" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Summary of Molecular Genetic Testing Used in Mucolipidosis IV</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1214/table/ml4.T.summary_of_molecular_genetic_testi/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml4.T.summary_of_molecular_genetic_testi_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_2" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Method</th></tr><tr><th headers="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_3" id="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a></th><th headers="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_3" id="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Non-<a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a></th></tr></thead><tbody><tr><td headers="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>MCOLN1</i></td><td headers="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Targeted analysis for pathogenic variants&#x000a0;<sup>3</sup></td><td headers="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_3 hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">95%</td><td headers="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_3 hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6%-10%</td></tr><tr><td headers="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4,&#x000a0;5</sup></td><td headers="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_3 hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">77%-81%</td><td headers="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_3 hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">99%</td></tr><tr><td headers="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6,&#x000a0;7</sup></td><td headers="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_3 hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">18% / unknown&#x000a0;<sup>8</sup></td><td headers="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_3 hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>8</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="ml4.TF.1.1"><p class="no_margin">See <a href="/books/NBK1214/#ml4.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="ml4.TF.1.2"><p class="no_margin">See <a href="#ml4.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="ml4.TF.1.3"><p class="no_margin">For the pathogenic variants <a class="figpopup" href="/books/NBK1214/table/ml4.T.selected_mcoln1_pathogenic_variant/?report=objectonly" target="object" rid-figpopup="figml4Tselectedmcoln1pathogenicvariant" rid-ob="figobml4Tselectedmcoln1pathogenicvariant">c.406-2A&#x0003e;G</a> (77%) and 6.4 kb del (18%). Note: Reported breakpoints for this <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> vary slightly; see <a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=MCOLN1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGMD</a>.</p></div></dd><dt>4. </dt><dd><div id="ml4.TF.1.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="ml4.TF.1.5"><p class="no_margin">Cannot detect <a class="figpopup" href="/books/NBK1214/table/ml4.T.selected_mcoln1_pathogenic_variant/?report=objectonly" target="object" rid-figpopup="figml4Tselectedmcoln1pathogenicvariant" rid-ob="figobml4Tselectedmcoln1pathogenicvariant">6.4 kb del</a>, one the two pathogenic variants common in persons of <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> heritage</p></div></dd><dt>6. </dt><dd><div id="ml4.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>7. </dt><dd><div id="ml4.TF.1.7"><p class="no_margin">Required to detect the common 6.4-kb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> observed in persons of <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> heritage and other novel (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions. Note that other <a class="def" href="/books/n/gene/glossary/def-item/genotyping/">genotyping</a> assays specifically designed to detect the 6.4-kb deletion (e.g., breakpoint <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> or <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>-specific primer extension) may be employed.</p></div></dd><dt>8. </dt><dd><div id="ml4.TF.1.8"><p class="no_margin">No data on detection rate of non-6.4-kb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd></dl></div></div></div></div><div id="ml4.Biopsy"><h4>Biopsy</h4><p>In the past, identification of abnormal lamellar membrane structures and amorphous cytoplasmic inclusions in diverse cell types on skin biopsy was used to confirm the diagnosis of mucolipidosis IV [<a class="bk_pop" href="#ml4.REF.bargal.2002.199">Bargal et al 2002</a>]. Subsequently, demonstration of typical vacuolation by PAS staining of conjunctival cells obtained with a swab was used for diagnosis [<a class="bk_pop" href="#ml4.REF.smith.2002.588">Smith et al 2002</a>].</p></div></div></div><div id="ml4.Clinical_Characteristics"><h2 id="_ml4_Clinical_Characteristics_">Clinical Characteristics</h2><div id="ml4.Clinical_Description"><h3>Clinical Description</h3><p>Mucolipidosis IV is a neurodevelopmental disorder that is also neurodegenerative in about 15% of individuals. The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals can be either typical (~95% of individuals) or atypical (~5% of individuals) [<a class="bk_pop" href="#ml4.REF.altarescu.2002.306">Altarescu et al 2002</a>]. Although individuals with mucolipidosis IV generally survive to adulthood, life expectancy is reduced compared to healthy individuals.</p><div id="ml4.Typical_Mucolipidosis_IV"><h4>Typical Mucolipidosis IV</h4><p>The most common presentation is severe psychomotor delay by the end of the first year of life in a child who is subsequently noted to have visual impairment caused by a combination of corneal clouding and retinal degeneration.</p><p><b>Neurologic findings.</b> Psychomotor development is usually limited to few or no words and poor hand use [<a class="bk_pop" href="#ml4.REF.altarescu.2002.306">Altarescu et al 2002</a>]; some may develop the ability to sit independently or crawl. Most individuals do not achieve independent walking [<a class="bk_pop" href="#ml4.REF.altarescu.2002.306">Altarescu et al 2002</a>]; a few have learned to walk with the aid of a walker [<a class="bk_pop" href="#ml4.REF.altarescu.2002.306">Altarescu et al 2002</a>].</p><p>Receptive language is better than expressive language; some individuals have used up to 50 signs to communicate.</p><p>Neurologic examination typically reveals severe dysarthria or anarthria, slow chewing, slow eating and swallowing, and spastic diplegia or quadriplegia [<a class="bk_pop" href="#ml4.REF.altarescu.2002.306">Altarescu et al 2002</a>]. Individuals may be hypotonic, but tendon reflexes are usually hyperactive.</p><p>Neurologic deficits generally remain static during the first three decades of life [<a class="bk_pop" href="#ml4.REF.altarescu.2002.306">Altarescu et al 2002</a>]; however, some individuals have neurologic deterioration best observed by serial brain magnetic resonance imaging volumetry and diffusion weighted imaging [<a class="bk_pop" href="#ml4.REF.schiffmann.2014.147">Schiffmann et al 2014</a>].</p><p>Brain MRI typically shows hypoplasia of the corpus callosum with absent rostrum and a dysplastic or absent splenium, signal abnormalities in the white matter on T<sub>1</sub>-weighted images, and increased ferritin deposition in the thalamus and basal ganglia. Atrophy of the cerebellum is observed in older individuals [<a class="bk_pop" href="#ml4.REF.frei.1998.565">Frei et al 1998</a>].</p><p>Epileptiform discharges on EEG are common but are infrequently associated with clinical seizures [<a class="bk_pop" href="#ml4.REF.siegel.1998.400">Siegel et al 1998</a>].</p><p><b>Eye findings.</b> Individuals with typical mucolipidosis IV have superficial corneal clouding that is bilateral, symmetric, and most visible in the central cornea [<a class="bk_pop" href="#ml4.REF.smith.2002.588">Smith et al 2002</a>]. The corneal opacification is limited to the epithelium without stromal involvement or edema [Authors, personal observation], early reports of stromal abnormalities notwithstanding. On occasion, corneal clouding is the feature that prompts medical evaluation.</p><p>Painful episodes consistent with corneal erosions are common, but appear to decrease in frequency and severity with age.</p><p>Vision may be close to normal at a young age. Over the first decade of life, progressive retinal degeneration with varying degrees of vascular attenuation, retinal pigment epithelial changes, and optic nerve pallor result in further decrease in vision [<a class="bk_pop" href="#ml4.REF.siegel.1998.400">Siegel et al 1998</a>, <a class="bk_pop" href="#ml4.REF.altarescu.2002.306">Altarescu et al 2002</a>, <a class="bk_pop" href="#ml4.REF.pradhan.2002.45">Pradhan et al 2002</a>, <a class="bk_pop" href="#ml4.REF.smith.2002.588">Smith et al 2002</a>]. Bilateral bull's eye maculopathy was observed in one individual [<a class="bk_pop" href="#ml4.REF.smith.2002.588">Smith et al 2002</a>]. Visual acuity is difficult to test in most individuals with mucolipidosis IV, but is decreased in almost all persons older than age five years. Virtually all individuals with mucolipidosis IV develop severe visual impairment by their early teens as a result of the retinal degeneration.</p><p>In rare instances, mucolipidosis IV may consist of <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> retinal dystrophy [<a class="bk_pop" href="#ml4.REF.goldin.2008.3134">Goldin et al 2008</a>].</p><p>Other ocular findings are strabismus (&#x0003e;50% of individuals), nystagmus, ptosis, and cataract [<a class="bk_pop" href="#ml4.REF.bach.2001.197">Bach 2001</a>, <a class="bk_pop" href="#ml4.REF.smith.2002.588">Smith et al 2002</a>]. The pupillary response to light is usually sluggish without evidence of relative afferent pupillary defect [<a class="bk_pop" href="#ml4.REF.smith.2002.588">Smith et al 2002</a>].</p><p><b>Renal findings.</b> Progressive renal failure which has been recognized in recent years is now considered a feature of the classic form of mucolipidosis IV. It manifests itself in the third decade of life [Author, unpublished data]. Because of chronic muscle atrophy in mucolipidosis IV, blood cystatin c level is the most sensitive way to diagnose renal insufficiency.</p><p><b>Other.</b> Iron deficiency occurs in about 50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, and iron deficiency anemia, which is usually well tolerated, occurs in about 10% of affected individuals [<a class="bk_pop" href="#ml4.REF.altarescu.2002.306">Altarescu et al 2002</a>].</p><p>The achlorhydria is asymptomatic.</p><p>The face is not typically coarse but has typical features [<a class="bk_pop" href="#ml4.REF.goldin.b">Goldin et al 2004b</a>].</p><p>Affected individuals do not have hepatosplenomegaly or specific skeletal abnormalities.</p></div><div id="ml4.Atypical_and_Mild_Mucolipidosis_IV"><h4>Atypical and Mild Mucolipidosis IV</h4><p>Individuals with atypical mucolipidosis IV are less severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> than individuals with typical mucolipidosis IV or have one organ system disproportionately affected [<a class="bk_pop" href="#ml4.REF.altarescu.2002.306">Altarescu et al 2002</a>].</p><p>Some individuals attain the ability to walk independently or have <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> dystrophic retinopathy without neurologic dysfunction [<a class="bk_pop" href="#ml4.REF.goldin.2008.3134">Goldin et al 2008</a>]. They develop slowly progressive ataxia, have mild eye abnormalities, and are usually of non-<a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> descent [<a class="bk_pop" href="#ml4.REF.altarescu.2002.306">Altarescu et al 2002</a>].</p><p>Some present with a <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> myopathy with significant generalized hypotonia and elevated serum muscle creatine kinase (CK) concentration.</p><p>Some present with static (non-progressive) motor and cognitive delay and minimal ocular abnormalities.</p><ul><li class="half_rhythm"><div>One female who presented with progressive visual impairment with corneal clouding with the appearance of cornea verticillata, retinopathy, normal psychomotor development, and behavioral abnormalities developed unstable gait in her twenties [<a class="bk_pop" href="#ml4.REF.altarescu.2002.306">Altarescu et al 2002</a>].</div></li><li class="half_rhythm"><div>Two other individuals with no neurologic deficit were diagnosed based on ocular findings [<a class="bk_pop" href="#ml4.REF.dobrovolny.2007.663">Dobrovolny et al 2007</a>, <a class="bk_pop" href="#ml4.REF.goldin.2008.3134">Goldin et al 2008</a>]. These individuals had all the other typical features of mucolipidosis IV including achlorhydria and autofluorescent inclusions in cultured skin fibroblasts [<a class="bk_pop" href="#ml4.REF.dobrovolny.2007.663">Dobrovolny et al 2007</a>, <a class="bk_pop" href="#ml4.REF.goldin.2008.3134">Goldin et al 2008</a>].</div></li></ul></div></div><div id="ml4.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Individuals of <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> ancestry usually have the severe form of mucolipidosis IV.</p><p>A <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that creates a new preferred <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> of <i>MCOLN1,</i>
<a class="figpopup" href="/books/NBK1214/table/ml4.T.selected_mcoln1_pathogenic_variant/?report=objectonly" target="object" rid-figpopup="figml4Tselectedmcoln1pathogenicvariant" rid-ob="figobml4Tselectedmcoln1pathogenicvariant">c.1406A&#x0003e;G</a> (p.Phe454_Asn569del) was identified in a Canadian family from Newfoundland; it causes an atypical form of mucolipidosis IV, in which <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals walk independently and have better communicative skills [<a class="bk_pop" href="#ml4.REF.altarescu.2002.306">Altarescu et al 2002</a>].</p><p><b>Variants in the loop between the first and second transmembrane <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>.</b> Pathogenic variants found in the loop between the first and second transmembrane domain, one in the lipase domain and one eliminating one of the four cysteines in the loop, possibly reduce the stability of mucolipin-1. Individuals with these pathogenic variants had a mild <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, an independent ataxic gait, and the ability to use their hands to feed themselves.</p><p>The typical, rather severe presentation associated with the <a class="figpopup" href="/books/NBK1214/table/ml4.T.selected_mcoln1_pathogenic_variant/?report=objectonly" target="object" rid-figpopup="figml4Tselectedmcoln1pathogenicvariant" rid-ob="figobml4Tselectedmcoln1pathogenicvariant">c.694A&#x0003e;C</a> (p.Thr232Pro) <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the same region may be explained by the fact that the abnormal protein does not reach the endocytic compartment and accumulates in the endoplasmic reticulum [<a class="bk_pop" href="#ml4.REF.manzoni.2004.219">Manzoni et al 2004</a>].</p><p><b>Variants in the third transmembrane <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>.</b> In several individuals from the southeast United States, a c.1084G&#x0003e;T (<a class="figpopup" href="/books/NBK1214/table/ml4.T.selected_mcoln1_pathogenic_variant/?report=objectonly" target="object" rid-figpopup="figml4Tselectedmcoln1pathogenicvariant" rid-ob="figobml4Tselectedmcoln1pathogenicvariant">p.Asp362Tyr</a>) <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was identified in the third transmembrane domain. This pathogenic variant was associated with a slower progression of the retinal disease and a relatively mild neurologic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, although membrane preparations containing mucolipin-1 with this pathogenic variant had no channel activity [<a class="bk_pop" href="#ml4.REF.raychowdhury.2004.617">Raychowdhury et al 2004</a>].</p><p><b>Variants in the fourth transmembrane <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>.</b> Several <i>MCOLN1</i> pathogenic variants are in the fourth transmembrane domain, including c.1221_1223delCTT (<a class="figpopup" href="/books/NBK1214/table/ml4.T.selected_mcoln1_pathogenic_variant/?report=objectonly" target="object" rid-figpopup="figml4Tselectedmcoln1pathogenicvariant" rid-ob="figobml4Tselectedmcoln1pathogenicvariant">p.Phe408del</a>), which causes the mildest mucolipidosis IV <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> known [<a class="bk_pop" href="#ml4.REF.altarescu.2002.306">Altarescu et al 2002</a>].</p><p><b>Variants between the fifth and sixth transmembrane <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>.</b> Several other pathogenic variants are in the area encoding the presumed channel pore between the fifth and sixth transmembrane domain. Most of those were associated with a severe mucolipidosis IV <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (<a class="figpopup" href="/books/NBK1214/table/ml4.T.selected_mcoln1_pathogenic_variant/?report=objectonly" target="object" rid-figpopup="figml4Tselectedmcoln1pathogenicvariant" rid-ob="figobml4Tselectedmcoln1pathogenicvariant">Table 3</a>) [<a class="bk_pop" href="#ml4.REF.altarescu.2002.306">Altarescu et al 2002</a>].</p></div><div id="ml4.Nomenclature"><h3>Nomenclature</h3><p>Mucolipidosis IV was classified as a mucolipidosis because of the initial impression of simultaneous storage of lipids and water-soluble substances.</p></div><div id="ml4.Prevalence"><h3>Prevalence</h3><p>The combined <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> frequency of the two pathogenic variants common in persons of <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> descent ranges from 1:100 to 1:127 [<a class="bk_pop" href="#ml4.REF.bargal.2001.397">Bargal et al 2001</a>, <a class="bk_pop" href="#ml4.REF.edelmann.2002.1023">Edelmann et al 2002</a>]. Of note, in a small group of 123 individuals, other investigators found a higher frequency [<a class="bk_pop" href="#ml4.REF.wang.2001.87">Wang et al 2001</a>].</p><ul><li class="half_rhythm"><div>The splice <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (c.406-2A&#x0003e;G) is at least three times more common than the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> pathogenic variant (6.4-kb del) [<a class="bk_pop" href="#ml4.REF.edelmann.2002.1023">Edelmann et al 2002</a>].</div></li><li class="half_rhythm"><div>The <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> variant is particularly rare in the Israeli population (1:2000) in comparison to its frequency in the New York metropolitan area (1:406) [<a class="bk_pop" href="#ml4.REF.bargal.2001.397">Bargal et al 2001</a>, <a class="bk_pop" href="#ml4.REF.edelmann.2002.1023">Edelmann et al 2002</a>].</div></li></ul><p>Prior to the availability of molecular diagnosis of mucolipidosis IV, individuals with atypical mucolipidosis IV were thought to have cerebral palsy, suggesting that mucolipidosis IV is underdiagnosed.</p></div></div><div id="ml4.Genetically_Related_Allelic_Disorder"><h2 id="_ml4_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are associated with pathogenic variants in <i>MCOLN1</i>.</p></div><div id="ml4.Differential_Diagnosis"><h2 id="_ml4_Differential_Diagnosis_">Differential Diagnosis</h2><p>Because of the relatively static nature of the neurologic abnormality in mucolipidosis IV, individuals considered to have "cerebral palsy" should be evaluated for mucolipidosis IV.</p><p>The neurologic abnormalities and the finding of widespread storage material in tissue biopsy could suggest other lysosomal storage disorders including mucolipidosis type I (OMIM <a href="http://omim.org/entry/256550" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">256550</a>), <a href="/books/n/gene/ml2/">mucolipidosis type II</a>, and the mucopolysaccharidoses (<a href="/books/n/gene/mps1/">MPS I</a>, <a href="/books/n/gene/hunter/">MPS II</a>, <a href="/books/n/gene/mps4a/">MPS IVA</a>, <a href="/books/n/gene/gm1-ganglio/">MPS IVB</a>). See <a href="http://www.omim.org/phenotypicSeries/PS607014" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Mucopolysaccharidoses: OMIM Phenotypic Series</a> to view genes associated with this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in OMIM.</p><p>The finding of white matter abnormalities and a thin dysplastic corpus callosum could suggest other inherited hypomyelinating leukodystrophies such as sialic acid storage disease (Salla disease). (See <a href="/books/n/gene/issd/">Free Sialic Acid Storage Disorders</a> and <a href="/books/n/gene/leukodys-ov/">Leukodystrophy Overview</a>.)</p><p>Corneal clouding also occurs in:</p><ul><li class="half_rhythm"><div>The mucopolysaccharidoses: <a href="/books/n/gene/mps1/">MPS I</a>, MPS III (OMIM <a href="http://omim.org/entry/252900" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">252900</a>, <a href="http://omim.org/entry/252930" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">252930</a>), <a href="/books/n/gene/mps4a/">MPS IVA</a>, <a href="/books/n/gene/gm1-ganglio/">MPS IVB</a>, MPS VI (OMIM <a href="http://omim.org/entry/253200" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">253200</a>);</div></li><li class="half_rhythm"><div>Mucolipidosis (<a href="/books/n/gene/ml2/">ML II</a>, <a href="/books/n/gene/ml2/">ML III alpha/beta</a>, <a href="/books/n/gene/ml3c/">ML III gamma</a>);</div></li><li class="half_rhythm"><div><a href="/books/n/gene/gm1-ganglio/">GM1 gangliosidosis</a>.</div></li></ul><p>Cornea verticillata (without retinal dystrophy) occurs in <a href="/books/n/gene/fabry/">Fabry disease</a>.</p><p>The retinal dystrophy of mucolipidosis IV is similar to that observed in the neuronal ceroid-lipofuscinoses and other genetic disorders with retinal degeneration such as <a href="/books/n/gene/bbs/">Bardet-Biedl syndrome</a> and <a href="/books/n/gene/alstrom/">Alstr&#x000f6;m syndrome</a>.</p></div><div id="ml4.Management"><h2 id="_ml4_Management_">Management</h2><div id="ml4.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with mucolipidosis IV, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Ophthalmic examination</div></li><li class="half_rhythm"><div>Brain MRI</div></li><li class="half_rhythm"><div>Iron studies</div></li><li class="half_rhythm"><div>Neurologic evaluation, including EEG</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="ml4.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>The following treatment is appropriate:</p><ul><li class="half_rhythm"><div>Speech therapy</div></li><li class="half_rhythm"><div>Physical therapy and rehabilitation for motor dysfunction (mainly spasticity and ataxia)</div></li><li class="half_rhythm"><div>Ankle-foot orthotics in individuals with hypotonia and weakness of ankle dorsiflexion</div></li><li class="half_rhythm"><div>Antiepileptic drugs</div></li><li class="half_rhythm"><div>Topical lubricating eye drops, artificial tears, gels, or ointments for management of the intermittent ocular irritation seen frequently in younger children</div></li><li class="half_rhythm"><div>Surgical correction of strabismus</div></li><li class="half_rhythm"><div>High-contrast black and white materials for those with visual impairment</div></li></ul><p>Note: Corneal transplantation has not been successful because the donor corneal epithelium is eventually replaced by the abnormal host epithelium.</p></div><div id="ml4.Prevention_of_Secondary_Complication"><h3>Prevention of Secondary Complications</h3><p>Physical therapy and rehabilitation can help prevent permanent joint contractures.</p><p>An iron preparation such as oral ferrous sulfate is indicated for treatment of iron deficiency anemia resulting from poor absorption of dietary iron.</p></div><div id="ml4.Surveillance"><h3>Surveillance</h3><p>Annual follow up with a generalist is appropriate.</p></div><div id="ml4.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Chloroquine may be contraindicated, based on published research in patient cultured skin fibroblasts [<a class="bk_pop" href="#ml4.REF.goldin.1999.8562">Goldin et al 1999</a>].</p></div><div id="ml4.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#ml4.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="ml4.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="ml4.Genetic_Counseling"><h2 id="_ml4_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="ml4.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Mucolipidosis IV is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="ml4.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>MCOLN1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Individuals with mucolipidosis IV do not reproduce. No information is available regarding the ability of individuals with mild disease to reproduce.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each sib of the proband's parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>MCOLN1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="ml4.Heterozygote_Carrier_Detection"><h3>Heterozygote (Carrier) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>MCOLN1</i> pathogenic variants in the family.</p></div><div id="ml4.Population_Screening"><h3>Population Screening</h3><p>Because of the high <a class="def" href="/books/n/gene/glossary/def-item/carrier-rate/">carrier rate</a> in individuals of <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> descent and the availability of premarital, preconception, and prenatal <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> as well as <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a>, the two <i>MCOLN1</i> pathogenic variants commonly seen in persons of Ashkenazi Jewish heritage are often included in the panel of "Ashkenazi Jewish mutations" offered to individuals interested in preconception or prenatal risk assessment modification. Through this type of screening, couples in which both partners are carriers can be made aware of their status and risks before having <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children. Through genetic counseling and the option of prenatal testing, such families can, if they choose, bring to term only those pregnancies in which the fetus is unaffected.</p></div><div id="ml4.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="ml4.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>MCOLN1</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for mucolipidosis IV are possible.</p></div></div><div id="ml4.Resources"><h2 id="_ml4_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Mucolipidosis IV Foundation</b></div><div>3500 Piedmont Road</div><div>Suite 500</div><div>Atlanta GA 30305</div><div><b>Phone:</b> (877) ML4-5459 (654-5459)</div><div><b>Email:</b> www@ml4.org</div><div><a href="http://www.ml4.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ml4.org</a></div></li><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=Mucolipidosis%20IV&#x00026;parent=Metabolic%20Disorders&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Mucolipidosis IV</a></div></li><li class="half_rhythm"><div><b>National MPS Society</b></div><div>PO Box 14686</div><div>Durham NC 27709-4686</div><div><b>Phone:</b> 877-677-1001 (toll-free); 919-806-0101</div><div><b>Fax:</b> 919-806-2055</div><div><b>Email:</b> info@mpssociety.org</div><div><a href="http://www.mpssociety.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mpssociety.org</a></div></li><li class="half_rhythm"><div><b>Society for Mucopolysaccharide Diseases (MPS)</b></div><div>MPS House Repton Place</div><div>White Lion Road</div><div>Amersham Buckinghamshire HP7 9LP</div><div>United Kingdom</div><div><b>Phone:</b> 0345 389 9901</div><div><b>Email:</b> mps@mpssociety.co.uk</div><div><a href="http://www.mpssociety.co.uk" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mpssociety.co.uk</a></div></li><li class="half_rhythm"><div><b>Center for Jewish Genetics</b></div><div>Ben Gurion Way</div><div>30 South Wells Street</div><div>Chicago IL 60606</div><div><b>Phone:</b> 312-357-4718</div><div><b>Email:</b> jewishgeneticsctr@juf.org</div><div><a href="http://www.jewishgenetics.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.jewishgenetics.org</a></div></li></ul></div><div id="ml4.Molecular_Genetics"><h2 id="_ml4_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="ml4.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Mucolipidosis IV: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1214/table/ml4.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml4.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_ml4.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_ml4.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_ml4.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_ml4.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_ml4.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_ml4.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_ml4.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/57192" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>MCOLN1</i></a></td><td headers="hd_b_ml4.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=57192" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">19p13<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_ml4.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9GZU1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Mucolipin-1</a></td><td headers="hd_b_ml4.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/MCOLN1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MCOLN1 database</a></td><td headers="hd_b_ml4.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=MCOLN1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MCOLN1</a></td><td headers="hd_b_ml4.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=MCOLN1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MCOLN1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="ml4.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="ml4.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Mucolipidosis IV (<a href="/omim/252650,605248" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1214/table/ml4.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml4.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/252650" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">252650</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MUCOLIPIDOSIS IV; ML4</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/605248" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">605248</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MUCOLIPIN 1; MCOLN1</td></tr></tbody></table></div></div><div id="ml4.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>The lysosomal storage of lipids and water-soluble substances in mucolipidosis IV is attributed to a transport defect in the late steps of endocytosis resulting from abnormal membrane components of endosomes. Endosomes shuttle lipids and proteins between the plasma membrane and the various cellular organelles. Nutrients bound to lysosomes for processing would be retained in these transition vesicles. Alternatively it could indicate an increased rate of membrane recycling resulting from rapid degradation of malfunctioning protein complexes at the plasma membrane. Inability of cells to compensate for the missing cation channel function causes the defect in organization of white matter in the brain and reduces maintenance of cells in the retina and optic nerve. Inability to secrete gastric acid may be directly related to a defect in the operation of the acid-secreting H<sup>+</sup>K<sup>+</sup> ATPase in stomach parietal cells.</p><p>In <i>C elegans</i> a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in an ABC transporter <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> compensates for mucolipin deficiency and leads to viable worms, indicating that loss of a regulatory effect of mucolipin on the activity of the transporter is probably the cause of death in mucolipin-deficient worms [<a class="bk_pop" href="#ml4.REF.schaheen.2006.382">Schaheen et al 2006</a>].</p><p><b>Gene structure.</b>
<i>MCOLN1</i> spans 12,300 base pairs and comprises 14 exons. In humans, no expressed splice variants are known.</p><p><b>Benign variants.</b> A single-nucleotide <a class="def" href="/books/n/gene/glossary/def-item/polymorphism/">polymorphism</a>, c.984C&#x0003e;T (p.Asn328Asn), results in no amino acid change (reference sequence <a href="/nuccore/NM_020533.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_020533.1</a>).</p><p><b>Pathogenic variants.</b> A variety of pathogenic variants cause mucolipidosis IV, including pathogenic splice variants, small and large deletions and insertions, and pathogenic <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants (<a class="figpopup" href="/books/NBK1214/table/ml4.T.selected_mcoln1_pathogenic_variant/?report=objectonly" target="object" rid-figpopup="figml4Tselectedmcoln1pathogenicvariant" rid-ob="figobml4Tselectedmcoln1pathogenicvariant">Table 3</a>).</p><p>The two most prevalent pathogenic variants cause the majority of mucolipidosis IV in the <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> population.</p><ul><li class="half_rhythm"><div>One is the splice variant c.406-2A&#x0003e;G, which prevents <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> of mucolipin-1 <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> at <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 4, resulting in a mix of unstable aberrant mRNA species.</div></li><li class="half_rhythm"><div>The second, 6.4 kb del (also known as g.511_6943del), is a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 6434 bp of DNA, including exons 1 through 5 and part of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 6 of <i>MCOLN1</i>. A Polish individual with a non-Jewish haplotype was found to be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for this <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#ml4.REF.sun.2000.2471">Sun et al 2000</a>].</div></li></ul><p>Pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants were found in the loop between the first and second transmembrane <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, one in the lipase domain, and one eliminating the four cysteines in the loop, possibly reducing the stability of mucolipin. See <a href="/books/NBK1214/bin/ml4-Table2.pdf">Table 2</a> (pdf) for a summary of additional pathogenic variants not discussed in this review. For more information, see <a href="/books/NBK1214/#ml4.molgen.TA">Table A</a>.</p><p>The variant c.1221_1223delCTT (<a class="figpopup" href="/books/NBK1214/table/ml4.T.selected_mcoln1_pathogenic_variant/?report=objectonly" target="object" rid-figpopup="figml4Tselectedmcoln1pathogenicvariant" rid-ob="figobml4Tselectedmcoln1pathogenicvariant">p.Phe408del</a>), located in the fourth transmembrane <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, causes the mildest mucolipidosis IV <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> known [<a class="bk_pop" href="#ml4.REF.altarescu.2002.306">Altarescu et al 2002</a>]. In vitro the protein construct with this <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> still functions as a channel in liposome preparations and only displays a deficiency in regulation [<a class="bk_pop" href="#ml4.REF.raychowdhury.2004.617">Raychowdhury et al 2004</a>]. Overexpressed Phe408del variant retains Fe2+ channel permeability as indicated by Patch-clamping of late-endosomal and lysosomal membrane [<a class="bk_pop" href="#ml4.REF.dong.2008.992">Dong et al 2008</a>], possibly underlying the milder disease phenotype in this individual.</p><div id="ml4.T.selected_mcoln1_pathogenic_variant" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Selected <i>MCOLN1</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1214/table/ml4.T.selected_mcoln1_pathogenic_variant/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml4.T.selected_mcoln1_pathogenic_variant_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequence</th></tr></thead><tbody><tr><td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.406-2A&#x0003e;G<br />(IVS3-2A&#x0003e;G)</td><td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/260763972" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_020533<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/nuccore/9844925" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AF287270</a></td></tr><tr><td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6.4-kb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a><br />(g.511_6943del)</td><td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deletion of exons 1-5 and part of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 6</td><td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/9844925" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AF287270</a></td></tr><tr><td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.694A&#x0003e;C</td><td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr232Pro</td><td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_3" rowspan="6" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/260763972" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_020533<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1084G&#x0003e;T</td><td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp362Tyr</td></tr><tr><td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1221_1223delCTT</td><td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Phe408del</td></tr><tr><td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1406A&#x0003e;G&#x000a0;<sup>2</sup><br />(g.9107A&#x0003e;G)</td><td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Phe454_Asn569del</td></tr><tr><td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">c.1704A&#x0003e;T&#x000a0;<sup>3</sup></td><td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 3</td></tr><tr><td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">c.1615delG&#x000a0;<sup>4</sup></td><td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala539ProfsTer41&#x000a0;<sup>4</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="ml4.TF.3.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd><dt>2. </dt><dd><div id="ml4.TF.3.2"><p class="no_margin">Base pair transition creates a new preferred splice acceptor site that results in a frameshift.</p></div></dd><dt>3. </dt><dd><div id="ml4.TF.3.3"><p class="no_margin">Near the donor site of <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 13; creates an alternative donor <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> that results in a frameshift [<a class="bk_pop" href="#ml4.REF.dobrovolny.2007.663">Dobrovolny et al 2007</a>]</p></div></dd><dt>4. </dt><dd><div id="ml4.TF.3.4"><p class="no_margin"><a class="bk_pop" href="#ml4.REF.goldin.2008.3134">Goldin et al [2008]</a></p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Mucolipin-1 is a 580-amino acid protein that is a member of the transient receptor potential (TRP) family. Proteins of this family are generally considered Ca<sup>2+</sup> channels. Mucolipin-1 has a high homology to mucolipin-2 and mucolipin-3. It also shows homologies to polycystin-2, the product of <i>PKD2</i>, one of two genes associated with <a href="/books/n/gene/pkd-ad/">autosomal dominant polycystic kidney disease</a>. Mucolipin-1 and polycystin-2 function as nonselective cation channels in heterologous expression systems [<a class="bk_pop" href="#ml4.REF.fares.2001.64">Fares &#x00026; Greenwald 2001</a>, <a class="bk_pop" href="#ml4.REF.laplante.2002.183">LaPlante et al 2002</a>, <a class="bk_pop" href="#ml4.REF.slaugenhaupt.2002.445">Slaugenhaupt 2002</a>, <a class="bk_pop" href="#ml4.REF.raychowdhury.2004.617">Raychowdhury et al 2004</a>, <a class="bk_pop" href="#ml4.REF.treusch.2004.4483">Treusch et al 2004</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Most pathogenic variants are <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> alleles resulting in no gene product. When an abnormal gene product exists, it is a nonfunctional protein.</p></div></div><div id="ml4.References"><h2 id="_ml4_References_">References</h2><div id="ml4.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="ml4.REF.altarescu.2002.306">Altarescu G, Sun M, Moore DF, Smith JA, Wiggs EA, Solomon BI, Patronas NJ, Frei KP, Gupta S, Kaneski CR, Quarrell OW, Slaugenhaupt SA, Goldin E, Schiffmann R. The neurogenetics of mucolipidosis type IV. <span><span class="ref-journal">Neurology. </span>2002;<span class="ref-vol">59</span>:306–13.</span> [<a href="/pubmed/12182165" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12182165</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml4.REF.bach.2001.197">Bach G. Mucolipidosis type IV. <span><span class="ref-journal">Mol Genet Metab. </span>2001;<span class="ref-vol">73</span>:197–203.</span> [<a href="/pubmed/11461186" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11461186</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml4.REF.bargal.2000.118">Bargal R, Avidan N, Ben-Asher E, Olender Z, Zeigler M, Frumkin A, Raas-Rothschild A, Glusman G, Lancet D, Bach G. Identification of the gene causing mucolipidosis type IV. <span><span class="ref-journal">Nat Genet. </span>2000;<span class="ref-vol">26</span>:118–23.</span> [<a href="/pubmed/10973263" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10973263</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml4.REF.bargal.2001.397">Bargal R, Avidan N, Olender T, Ben Asher E, Zeigler M, Raas-Rothschild A, Frumkin A, Ben-Yoseph O, Friedlender Y, Lancet D, Bach G. Mucolipidosis type IV: novel MCOLN1 mutations in Jewish and non-Jewish patients and the frequency of the disease in the Ashkenazi Jewish population. <span><span class="ref-journal">Hum Mutat. </span>2001;<span class="ref-vol">17</span>:397–402.</span> [<a href="/pubmed/11317355" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11317355</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml4.REF.bargal.2002.199">Bargal R, Goebel HH, Latta E, Bach G. Mucolipidosis IV: novel mutation and diverse ultrastructural spectrum in the skin. <span><span class="ref-journal">Neuropediatrics. </span>2002;<span class="ref-vol">33</span>:199–202.</span> [<a href="/pubmed/12368990" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12368990</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml4.REF.bassi.2000.1110">Bassi MT, Manzoni M, Monti E, Pizzo MT, Ballabio A, Borsani G. Cloning of the gene encoding a novel integral membrane protein, mucolipidin-and identification of the two major founder mutations causing mucolipidosis type IV. <span><span class="ref-journal">Am J Hum Genet. </span>2000;<span class="ref-vol">67</span>:1110–20.</span> [<a href="/pmc/articles/PMC1288553/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1288553</span></a>] [<a href="/pubmed/11013137" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11013137</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml4.REF.dobrovolny.2007.663">Dobrovolny R, Liskova P, Ledvinova J, Poupetova H, Asfaw B, Filipec M, Jirsova K, Kraus J, Elleder M. Mucolipidosis IV: report of a case with ocular restricted phenotype caused by leaky splice mutation. <span><span class="ref-journal">Am J Ophthalmol. </span>2007;<span class="ref-vol">143</span>:663–71.</span> [<a href="/pubmed/17239335" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17239335</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml4.REF.dong.2008.992">Dong XP, Cheng X, Mills E, Delling M, Wang F, Kurz T, Xu H. The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel. <span><span class="ref-journal">Nature. </span>2008;<span class="ref-vol">455</span>:992–6.</span> [<a href="/pmc/articles/PMC4301259/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4301259</span></a>] [<a href="/pubmed/18794901" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18794901</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml4.REF.edelmann.2002.1023">Edelmann L, Dong J, Desnick RJ, Kornreich R. Carrier screening for mucolipidosis type IV in the American Ashkenazi Jewish population. <span><span class="ref-journal">Am J Hum Genet. </span>2002;<span class="ref-vol">70</span>:1023–7.</span> [<a href="/pmc/articles/PMC379096/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC379096</span></a>] [<a href="/pubmed/11845410" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11845410</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml4.REF.fares.2001.64">Fares H, Greenwald I. Regulation of endocytosis by CUP-5, the Caenorhabditis elegans mucolipin-1 homolog. <span><span class="ref-journal">Nat Genet. </span>2001;<span class="ref-vol">28</span>:64–8.</span> [<a href="/pubmed/11326278" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11326278</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml4.REF.frei.1998.565">Frei KP, Patronas NJ, Crutchfield KE, Altarescu G, Schiffmann R. Mucolipidosis type IV: characteristic MRI findings. <span><span class="ref-journal">Neurology. </span>1998;<span class="ref-vol">51</span>:565–9.</span> [<a href="/pubmed/9710036" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9710036</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml4.REF.goldin.2008.3134">Goldin E, Caruso RC, Benko W, Kaneski CR, Stahl S, Schiffmann R. Isolated ocular disease is associated with decreased mucolipin-1 channel conductance. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2008;<span class="ref-vol">49</span>:3134–42.</span> [<a href="/pmc/articles/PMC5267708/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5267708</span></a>] [<a href="/pubmed/18326692" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18326692</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml4.REF.goldin.1999.8562">Goldin E, Cooney A, Kaneski CR, Brady RO, Schiffmann R. Mucolipidosis IV consists of one complementation group. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1999;<span class="ref-vol">96</span>:8562–6.</span> [<a href="/pmc/articles/PMC17556/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC17556</span></a>] [<a href="/pubmed/10411915" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10411915</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml4.REF.goldin.2004a.460">Goldin E, Stahl S, Cooney AM, Kaneski CR, Gupta S, Brady RO, Ellis JR, Schiffmann R. Transfer of a mitochondrial DNA fragment to MCOLN1 causes an inherited case of mucolipidosis IV. <span><span class="ref-journal">Hum Mutat. </span>2004a;<span class="ref-vol">24</span>:460–5.</span> [<a href="/pubmed/15523648" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15523648</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml4.REF.goldin.b">Goldin M, Slaugenhaupt SA, Smith JA, Schiffmann R. Mucolipidosis type IV. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. <em>The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID)</em>. Chap 138.1. New York, NY: McGraw-Hill. 2004b.</div></li><li class="half_rhythm"><div class="bk_ref" id="ml4.REF.laplante.2002.183">LaPlante JM, Falardeau J, Sun M, Kanazirska M, Brown EM, Slaugenhaupt SA, Vassilev PM. Identification and characterization of the single channel function of human mucolipin-1 implicated in mucolipidosis type IV, a disorder affecting the lysosomal pathway. <span><span class="ref-journal">FEBS Lett. </span>2002;<span class="ref-vol">532</span>:183–7.</span> [<a href="/pubmed/12459486" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12459486</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml4.REF.manzoni.2004.219">Manzoni M, Monti E, Bresciani R, Bozzato A, Barlati S, Bassi MT, Borsani G. Overexpression of wild-type and mutant mucolipin proteins in mammalian cells: effects on the late endocytic compartment organization. <span><span class="ref-journal">FEBS Lett. </span>2004;<span class="ref-vol">567</span>:219–24.</span> [<a href="/pubmed/15178326" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15178326</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml4.REF.pradhan.2002.45">Pradhan SM, Atchaneeyasakul LO, Appukuttan B, Mixon RN, McFarland TJ, Billingslea AM, Wilson DJ, Stout JT, Weleber RG. Electronegative electroretinogram in mucolipidosis IV. <span><span class="ref-journal">Arch Ophthalmol. </span>2002;<span class="ref-vol">120</span>:45–50.</span> [<a href="/pubmed/11786056" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11786056</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml4.REF.raychowdhury.2004.617">Raychowdhury MK, Gonz&#x000e1;lez-Perrett S, Montalbetti N, Timpanaro GA, Chasan B, Goldmann WH, Stahl S, Cooney A, Goldin E, Cantiello HF. Molecular pathophysiology of mucolipidosis type IV: pH dysregulation of the mucolipin-1 cation channel. <span><span class="ref-journal">Hum Mol Genet. </span>2004;<span class="ref-vol">13</span>:617–27.</span> [<a href="/pubmed/14749347" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14749347</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml4.REF.schaheen.2006.382">Schaheen L, Dang H, Fares H. Basis of lethality in C. elegans lacking CUP-5, the mucolipidosis type IV orthologue. <span><span class="ref-journal">Dev Biol. </span>2006;<span class="ref-vol">293</span>:382–91.</span> [<a href="/pubmed/16530747" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16530747</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml4.REF.schiffmann.1998.1207">Schiffmann R, Dwyer NK, Lubensky IA, Tsokos M, Sutliff VE, Latimer JS, Frei KP, Brady RO, Barton NW, Blanchette-Mackie EJ, Goldin E. Constitutive achlorhydria in mucolipidosis type IV. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1998;<span class="ref-vol">95</span>:1207–12.</span> [<a href="/pmc/articles/PMC18720/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC18720</span></a>] [<a href="/pubmed/9448310" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9448310</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml4.REF.schiffmann.2014.147">Schiffmann R, Mayfield J, Swift C, Nestrasil I. Quantitative neuroimaging in mucolipidosis type IV. <span><span class="ref-journal">Mol Genet Metab. </span>2014;<span class="ref-vol">111</span>:147–51.</span> [<a href="/pmc/articles/PMC4097300/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4097300</span></a>] [<a href="/pubmed/24332805" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24332805</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml4.REF.siegel.1998.400">Siegel H, Frei K, Greenfield J, Schiffmann R, Sato S. Electroencephalographic findings in patients with mucolipidosis type IV. <span><span class="ref-journal">Electroencephalogr Clin Neurophysiol. </span>1998;<span class="ref-vol">106</span>:400–3.</span> [<a href="/pubmed/9680151" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9680151</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml4.REF.slaugenhaupt.2002.445">Slaugenhaupt SA. The molecular basis of mucolipidosis type IV. <span><span class="ref-journal">Curr Mol Med. </span>2002;<span class="ref-vol">2</span>:445–50.</span> [<a href="/pubmed/12125810" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12125810</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml4.REF.smith.2002.588">Smith JA, Chan CC, Goldin E, Schiffmann R. Noninvasive diagnosis and ophthalmic features of mucolipidosis type IV. <span><span class="ref-journal">Ophthalmology. </span>2002;<span class="ref-vol">109</span>:588–94.</span> [<a href="/pubmed/11874766" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11874766</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml4.REF.sun.2000.2471">Sun M, Goldin E, Stahl S, Falardeau JL, Kennedy JC, Acierno JS Jr, Bove C, Kaneski CR, Nagle J, Bromley MC, Colman M, Schiffmann R, Slaugenhaupt SA. Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel. <span><span class="ref-journal">Hum Mol Genet. </span>2000;<span class="ref-vol">9</span>:2471–8.</span> [<a href="/pubmed/11030752" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11030752</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml4.REF.treusch.2004.4483">Treusch S, Knuth S, Slaugenhaupt SA, Goldin E, Grant BD, Fares H. Caenorhabditis elegans functional orthologue of human protein h-mucolipin-1 is required for lysosome biogenesis. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2004;<span class="ref-vol">101</span>:4483–8.</span> [<a href="/pmc/articles/PMC384773/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC384773</span></a>] [<a href="/pubmed/15070744" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15070744</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml4.REF.wang.2001.87">Wang ZH, Zeng B, Pastores GM, Raksadawan N, Ong E, Kolodny EH. Rapid detection of the two common mutations in Ashkenazi Jewish patients with mucolipidosis type IV. <span><span class="ref-journal">Genet Test. </span>2001;<span class="ref-vol">5</span>:87–92.</span> [<a href="/pubmed/11551108" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11551108</span></a>]</div></li></ul></div></div><div id="ml4.Chapter_Notes"><h2 id="_ml4_Chapter_Notes_">Chapter Notes</h2><div id="ml4.Author_History"><h3>Author History</h3><p>Ehud Goldin, PhD (2004-present)<br />Yulia Grishchuk, PhD (2015-present)<br />Raphael Schiffmann, MD, MHSc (2004-present)<br />Susan A Slaugenhaupt, PhD; Harvard Medical School (2004-2015)<br />Janine Smith, MD; National Institutes of Health (2004-2015)</p></div><div id="ml4.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>30 July 2015 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>20 July 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>6 June 2007 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>1 December 2005 (rs) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> no longer clinically available</div></li><li class="half_rhythm"><div>28 January 2005 (me) Review posted live</div></li><li class="half_rhythm"><div>16 August 2004 (rs) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1214</span><span class="label">PMID: <a href="/pubmed/20301393" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301393</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ml3c/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/mps1/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1214&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1214/?report=reader">PubReader</a></li><li><a href="/books/NBK1214/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1214" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1214" style="display:none" title="Cite this Page"><div class="bk_tt">Schiffmann R, Grishchuk Y, Goldin E. Mucolipidosis IV. 2005 Jan 28 [Updated 2015 Jul 30]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1214/pdf/Bookshelf_NBK1214.pdf">PDF version of this page</a> (181K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#ml4.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#ml4.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#ml4.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#ml4.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#ml4.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#ml4.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#ml4.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#ml4.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#ml4.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#ml4.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#ml4.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=57192[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MCOLN1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1463960" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1463960" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1463960" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1463960" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301446" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Gaucher Disease</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Gaucher Disease<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Pastores GM, Hughes DA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301726" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Insensitivity to Pain with Anhidrosis</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Insensitivity to Pain with Anhidrosis<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Indo Y. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301730" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mucolipidosis III Alpha/Beta</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mucolipidosis III Alpha/Beta<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Leroy JG, Cathey SS, Friez MJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301543" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Epidermolysis Bullosa Simplex</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Epidermolysis Bullosa Simplex<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Pfendner EG, Bruckner AL. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301481" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dystrophic Epidermolysis Bullosa</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dystrophic Epidermolysis Bullosa<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Pfendner EG, Lucky AW. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301393" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301393" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc941edde0891169cdbb71">Mucolipidosis IV - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Mucolipidosis IV - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:27:58-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE893BB9DFC8AE110000000004B00232&amp;ncbi_session=CE893BB9DFC941D1_1200SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1214%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1214&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1214/&amp;ncbi_pagename=Mucolipidosis IV - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE893BB9DFC941D1_1200SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>